Regeneron Pharmaceuticals | REGN - القيمة السوقية





القيمة السوقية تغيير تاريخ
AbbVie USD 444.6B 59.91B 2026-06
Agenus USD 128M 21M 2026-03
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
Amgen USD 195.44B 5.55B 2026-06
Astellas Pharma JPY 3.94T 622.52B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Biogen USD 31.9B 5B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Bristol-Myers Squibb USD 117.66B 6.17B 2026-06
Eli Lilly USD 1.13T 260.54B 2026-06
Gilead Sciences USD 156.86B 16.13B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
Incyte USD 22.65B 3.92B 2026-06
Ionis Pharmaceuticals USD 13.1B 642M 2026-06
J&J USD 599.65B 11.71B 2026-10
Kyowa Hakko Kirin JPY 1.36T 4.73B 2026-06
Merck USD 317.37B 20.27B 2026-06
Neurocrine Biosciences USD 16.95B 3.7B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Novartis USD 288.26B 25.18B 2026-03
Pfizer USD 138.44B 15.37B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 113.52B 3.82B 2026-03
Sarepta Therapeutics USD 1.9B 388M 2026-06
Teva Pharmaceutical Industries USD 114.54B 80.27B 2026-06
Ultragenyx Pharmaceutical USD 3.29B 1.23B 2026-06
United Therapeutics USD 23B 2.19B 2026-06
Vertex Pharmaceuticals USD 126.07B 12.49B 2026-06